Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation

J Neurochem. 2011 Apr;117(2):264-74. doi: 10.1111/j.1471-4159.2011.07198.x. Epub 2011 Feb 24.

Abstract

Glyceryl triacetate (GTA), a compound effective at increasing circulating and tissue levels of acetate was used to treat rats subjected to a continual 28 day intra-ventricular infusion of bacterial lipopolysaccharide (LPS). This model produces a neuroinflammatory injury characterized by global neuroglial activation and a decrease in choline acetyltransferase immunoreactivity in the basal forebrain. During the LPS infusion, rats were given a daily treatment of either water or GTA at a dose of 6 g/kg by oral gavage. In parallel experiments, free-CoA and acetyl-CoA levels were measured in microwave fixed brains and flash frozen heart, liver, kidney and muscle following a single oral dose of GTA. We found that a single oral dose of GTA significantly increased plasma acetate levels by 15 min and remained elevated for up to 4 h. At 30 min the acetyl-CoA levels in microwave-fixed brain and flash frozen heart and liver were increased at least 2.2-fold. The concentrations of brain acetyl-CoA was significantly increased between 30 and 45 min following treatment and remained elevated for up to 4 h. The concentration of free-CoA in brain was significantly decreased compared to controls at 240 min. Immunohistochemical and morphological analysis demonstrated that a daily treatment with GTA significantly reduced the percentage of reactive glial fibrillary acidic protein-positive astrocytes and activated CD11b-positive microglia by 40-50% in rats subjected to LPS-induced neuroinflammation. Further, in rats subjected to neuroinflammation, GTA significantly increased the number of choline acetyltransferase (ChAT)-positive cells by 40% in the basal forebrain compared to untreated controls. These data suggest that acetate supplementation increases intermediary short chain acetyl-CoA metabolism and that treatment is potentially anti-inflammatory and neuroprotective with regards to attenuating neuroglial activation and increasing ChAT immunoreactivity in this model.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetates / blood
  • Acetates / pharmacology*
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • CD11b Antigen / metabolism
  • Cell Count / methods
  • Choline O-Acetyltransferase / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Encephalitis / chemically induced*
  • Encephalitis / diet therapy*
  • Encephalitis / pathology
  • Gene Expression Regulation / drug effects
  • Glial Fibrillary Acidic Protein / metabolism
  • Lipopolysaccharides*
  • Male
  • Microglia / drug effects
  • Microglia / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Statistics, Nonparametric
  • Time Factors

Substances

  • Acetates
  • CD11b Antigen
  • Glial Fibrillary Acidic Protein
  • Lipopolysaccharides
  • Choline O-Acetyltransferase